Application of tissue-engineered interventions for coronary artery bypass grafts
Coronary artery bypass graft is one of the extensively conducted procedures to release occlusion in the coronary vessel. Various biological grafts are used for this purpose, superiorly, saphenous vein graft, if unavailable, other vessels in the body, with likewise characteristics are exploited for the purpose. The choice of graft is yet under discovery that could impeccably meet all the requirements. Variation in perioperative and postoperative results have given uneven clinical inferences of these conduits. Alternatively, tissue-engineering is also being applied in this area for clinical improvements. This review underlines some of the commonly used grafts for coronary artery bypass graft and advancements in tissue engineering for this purpose.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Future cardiology - 16(2020), 6 vom: 07. Nov., Seite 675-685 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Pooria, Ali [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Biological grafts |
|---|
| Anmerkungen: |
Date Completed 25.10.2021 Date Revised 25.10.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.2217/fca-2019-0050 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM312206704 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM312206704 | ||
| 003 | DE-627 | ||
| 005 | 20231225143920.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2217/fca-2019-0050 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1040.xml |
| 035 | |a (DE-627)NLM312206704 | ||
| 035 | |a (NLM)32643391 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Pooria, Ali |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Application of tissue-engineered interventions for coronary artery bypass grafts |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.10.2021 | ||
| 500 | |a Date Revised 25.10.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Coronary artery bypass graft is one of the extensively conducted procedures to release occlusion in the coronary vessel. Various biological grafts are used for this purpose, superiorly, saphenous vein graft, if unavailable, other vessels in the body, with likewise characteristics are exploited for the purpose. The choice of graft is yet under discovery that could impeccably meet all the requirements. Variation in perioperative and postoperative results have given uneven clinical inferences of these conduits. Alternatively, tissue-engineering is also being applied in this area for clinical improvements. This review underlines some of the commonly used grafts for coronary artery bypass graft and advancements in tissue engineering for this purpose | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a CABG | |
| 650 | 4 | |a biological grafts | |
| 650 | 4 | |a biomaterials | |
| 650 | 4 | |a coronary vessel | |
| 650 | 4 | |a saphenous vein graft | |
| 650 | 4 | |a tissue-engineering | |
| 700 | 1 | |a Pourya, Afsoun |e verfasserin |4 aut | |
| 700 | 1 | |a Gheini, Alireza |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Future cardiology |d 2005 |g 16(2020), 6 vom: 07. Nov., Seite 675-685 |w (DE-627)NLM187860939 |x 1744-8298 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2020 |g number:6 |g day:07 |g month:11 |g pages:675-685 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2217/fca-2019-0050 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2020 |e 6 |b 07 |c 11 |h 675-685 | ||